RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases with comprehensive and sustainable solutions. RareStone Group consists of two business subsidiaries: Citrine Medicine and Zircon Health. Citrine Medicine is a pharmaceutical company aiming to provide effective and affordable treatment solutions to rare disease patients in China. Citrine Medicine is building a comprehensive rare disease product platform through fast licensing and co-development to support and accelerate scalable commercialization. Zircon Health is a Health technology company aiming to build the largest patient-centered open ecological service platform in China with the help of cutting-edge technology. Zircon Health will leverage Internet digital tools, big data, and artificial intelligence technologies to improve the awareness of rare diseases, promote disease screening and diagnosis, carry out full-cycle disease management, and explore various payment innovations, providing comprehensive and one-stop health service solutions for patients and families affected by rare diseases.
  • Vision
    To become the LEADING company supporting the rare disease community in China.
  • Mission
    To provide individuals and families in China affected by rare diseases with ACCESS to the BEST, most effective medicines, and treatment protocols available in the world.
  • Approach
    Building the FIRST rare disease ecosystem in China to bring a support network and much-needed treatments to individuals and their families affected by rare disease.
  • Management Team
  • Advisory Board
  • Board Members
  • Investors
  • Management Team
    • Dr. Shawn Xiang

      Chief Executive Officer
       

    • Eileen Li

      Chief Business Officer
       

    • Andy Zhang

      VP, Head of Finance
       

    • Emily Huang

      Head of Clinical Portfolio Development
       

    • Hardy Huan

      VP, Head of Citrine Medicine
       

    • Vivian Dai

      VP, Head of Zircon Health
       

    • Haze Shi

      HR Director
       

  • Advisory Board
    • Dr. Xudong Yin

      Chairman of Advisory Board

    • Dr. Marlene Haffner

      Member of Advisory Board

    • Dr. Ruyi He

      Member of Advisory Board

  • Board Members
    (Listed Alphabetically by Last Name)
    • Rebecca Lin

      Senior Partner of Eight Roads

    • Dr. Hongbo Lu

      Partner of Vivo Capital

    • Dr. Mahendra G. Shah

      Managing Director of Vivo Capital

    • Dr. MinChuan Wang

      Partner and Managing Director of
        3H Health Investment

    • Dr. Marietta Wu

      Managing Director of Quan Capital
       

    • Dr. Shawn Xiang

      Chief Executive Officer of RareStone Group
       

    • Dr. Chong Xu

      Partner of F-Prime Capital